ArticleEJHaem2024
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy.
Francesca Fazio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it